Insider · CIK 0001864116

Bellinger Andrew

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001864116

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-14	Verve Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+45K sh	—	—	45,000
2024-02-14	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+180K sh	—	—	180,000
2023-02-14	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+183K sh	—	—	182,800
2022-12-14	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−36K sh	—	—	179,994
2022-12-14	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+36K sh	$2.87	+$103K	42,629
2022-12-01	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−865 sh	$22.95	−$19.9K	6,629
2022-10-28	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$39.90	−$399K	6,629
2022-10-28	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$1.48	+$14.8K	16,629
2022-10-28	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	86,995
2022-09-23	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−13.4K sh	$35.59	−$476K	6,629
2022-09-23	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$1.48	+$29.6K	26,629
2022-09-23	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,632 sh	$34.67	−$230K	19,997
2022-09-23	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+40K sh	$1.48	+$59.2K	46,629
2022-09-23	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−36.8K sh	$35.31	−$1.3M	9,831
2022-09-23	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,202 sh	$36.03	−$115K	6,629
2022-09-23	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−40K sh	—	—	96,995
2022-09-23	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	23,198
2022-07-20	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	1,599
2022-07-20	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$1.39	+$27.8K	26,629
2022-07-20	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−20K sh	$34.90	−$698K	6,629
2022-07-13	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$24.90	−$249K	6,629
2022-07-13	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	136,995
2022-07-13	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$1.48	+$14.8K	16,629
2022-02-11	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+125K sh	—	—	125,000
2021-12-22	Verve Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+15K sh	$1.48	+$22.2K	20,000
2021-12-22	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,968 sh	$37.42	−$73.6K	18,032
2021-12-22	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,161 sh	$38.60	−$315K	9,871
2021-12-22	Verve Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,871 sh	$39.37	−$192K	5,000
2021-12-22	Verve Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−15K sh	—	—	146,995
2021-12-16	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+55K sh	—	—	55,000
2021-06-21	Verve Therapeutics, Inc.P Purchase	Chief Scientific Officer	PPurchase	+5,000 sh	$19.00	+$95K	5,000
2021-06-17	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+21.6K sh	—	—	21,599

Recent filings

Accepted (ET)
Feb 164
Bellinger Andrew0000950170-24-016422
SEC(opens sec.gov)
Feb 164
Bellinger Andrew0001209191-23-010127
SEC(opens sec.gov)
Dec 164
Bellinger Andrew0001209191-22-061697
SEC(opens sec.gov)
Dec 24
Bellinger Andrew0001209191-22-059438
SEC(opens sec.gov)
Nov 14
Bellinger Andrew0001209191-22-055063
SEC(opens sec.gov)
Sep 274
Bellinger Andrew0001209191-22-051374
SEC(opens sec.gov)
Jul 224
Bellinger Andrew0001209191-22-043018
SEC(opens sec.gov)

Companies

Verve Therapeutics, Inc.Chief Scientific Officer

Address

C/O VERVE THERAPEUTICS, INC. 500 TECHNOLOGY SQUARE, SUITE 901

CAMBRIDGE, MA, 02139